By focusing on simpler ingredients and a lighter nutritional profile, MYOM offers an example of how oat drinks can fit naturally into GLP-1-aligned eating without compromising taste
Thus, in the early 1990s, pentadecapeptide BPC 157 [1,3,4,9,32,33,34,92] appeared as a late offshoot of the cytoprotectionorganoprotection concept of Robert and Szabo [32,33,34,35,36,37,38,39,40,41,42], for epithelial and endothelial protection
Gastrointestinal symptoms affect roughly 15 to 25% of people at this dose, though most are milder than what they experienced during initial titration
At the 12 mg dose over 48 weeks, participants lost an average of 24.2% of their body weight
DOI: 10.1056/NEJMoa2032183 : Jastreboff AM, Aronne LJ, et al
May cause weight loss Neither medication is FDA-approved as a weight loss drug